Ngā hua rapu - Christoph Kaiser
- E whakaatu ana i te 1 - 20 hua o te 45
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
-
4
Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial mā Thilo Burkard, Christoph Kaiser, Hans‐Peter Brunner‐La Rocca, Stefan Osswald, Matthias Pfisterer, Raban Jeger
I whakaputaina 2011Artigo -
5
Nakalanga Syndrome: Clinical Characteristics, Potential Causes, and Its Relationship with Recently Described Nodding Syndrome mā Kathrin Föger, Gina Gora‐Stahlberg, James J. Sejvar, Emilio Ovuga, Louise Jilek‐Aall, Erich Schmutzhard, Christoph Kaiser, Andrea S. Winkler
I whakaputaina 2017Revisão -
6
Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET mā Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca, Peter Rickenbacher, Patrick Hunziker, Christian Mueller, F. Nietlispach, Gregor Leibundgut, Franziska Bader, Christoph Kaiser
I whakaputaina 2008Artigo -
7
Drug-Eluting Stents Compared with Bare Metal Stents Improve Late Outcome after Saphenous Vein Graft but Not after Large Native Vessel Interventions mā Raban Jeger, Stefan Schneiter, Christoph Kaiser, Piero O. Bonetti, Hans‐Peter Brunner‐La Rocca, Michael Handke, Stefan Osswald, Peter Buser, Matthias Pfisterer
I whakaputaina 2008Artigo -
8
Epilepsy in Onchocerciasis Endemic Areas: Systematic Review and Meta-analysis of Population-Based Surveys mā Sébastien D. S. Pion, Christoph Kaiser, Fernand Boutros-Toni, Amandine Cournil, Melanie Taylor, S. E. O. Meredith, Ansgar Stüfe, I Bertocchi, Walter Kipp, Pierre‐Marie Preux, Michel Boussinesq
I whakaputaina 2009Revisão -
9
Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents mā Adnan Kastrati, Julinda Mehilli, Jürgen Pache, Christoph Kaiser, Marco Valgimigli, Henning Kelbæk, Maurizio Menichelli, Manel Sabaté, Maarten J. Suttorp, Dietrich Baumgart, Melchior Seyfarth, Matthias Pfisterer, Albert Schömig
I whakaputaina 2007Revisão -
10
Clinical Outcomes With Bioabsorbable Polymer- Versus Durable Polymer-Based Drug-Eluting and Bare-Metal Stents mā Tullio Palmerini, Giuseppe Biondi‐Zoccai, Diego Della Riva, Andrea Mariani, Manel Sabaté, Pieter C. Smits, Christoph Kaiser, Fabrizio D’Ascenzo, Giacomo Frati, Massimo Mancone, Philippe Généreux, Gregg W. Stone
I whakaputaina 2013Revisão -
11
Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI mā Thomas Pilgrim, Olivier Müller, Dik Heg, Marco Roffi, David J. Kurz, Igal Moarof, Daniel Weilenmann, Christoph Kaiser, Maxime Tapponnier, Sylvain Losdat, Éric Eeckhout, Marco Valgimigli, Peter Jüni, Stephan Windecker, Juan F. Iglesias
I whakaputaina 2021Artigo -
12
Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents mā Jochen Wöhrle, Bruno Scheller, Julia Seeger, Ahmed Farah, Marc‐Alexander Ohlow, Norman Mangner, Sven Möbius–Winkler, Daniel Weilenmann, Georg Stachel, Gregor Leibundgut, Peter Rickenbacher, Marco Cattaneo, Nicole Gilgen, Christoph Kaiser, Raban Jeger
I whakaputaina 2021Artigo -
13
Clinical Outcomes With Drug-Eluting and Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction mā Tullio Palmerini, Giuseppe Biondi‐Zoccai, Diego Della Riva, Andrea Mariani, Manel Sabaté, Marco Valgimigli, Giacomo Frati, Elvin Kedhi, Pieter C. Smits, Christoph Kaiser, Philippe Généreux, Søren Galatius, Ajay J. Kirtane, Gregg W. Stone
I whakaputaina 2013Artigo -
14
Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries mā Christoph Kaiser, S. Galatius, Paul Erné, Franz R. Eberli, Hannes Alber, Hans Rickli, Giovanni Pedrazzini, Burkhard Hornig, Osmund Bertel, Piero O. Bonetti, Stefano De Servi, Hans‐Peter Brunner‐La Rocca, Ingrid Ricard, Matthias Pfisterer
I whakaputaina 2010Artigo -
15
Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIO... mā Rainer Zbinden, Raffaele Piccolo, Dik Heg, Marco Roffi, David J. Kurz, Olivier Müller, André Vuilliomenet, Stéphane Cook, Daniel Weilenmann, Christoph Kaiser, Peiman Jamshidi, Anna Franzone, Franz R. Eberli, Peter Jüni, Stephan Windecker, Thomas Pilgrim
I whakaputaina 2016Artigo -
16
TCT-352 Long-term Clinical Data and Multimodality Imaging Analysis of the BIOSOLVE-II Study with the Drug-eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Nov... mā Michael Haude, Hüseyin İnce, Alexandre Abizaid, Ralph Töelg, Pedro A. Lemos, Clemens von Birgelen, Evald Høj Christiansen, Emanuele Barbato, Franz–Josef Neumann, Christoph Kaiser, Éric Eeckhout, Javier Escaned, Héctor M. García‐García, Ron Waksman
I whakaputaina 2018Artigo -
17
Stent Thrombosis With Everolimus-Eluting Stents mā Tullio Palmerini, Ajay J. Kirtane, Patrick W. Serruys, Pieter C. Smits, Elvin Kedhi, Dean J. Kereiakes, Diego Sangiorgi, Maria Letizia Bacchi Reggiani, Christoph Kaiser, Hyo‐Soo Kim, Antoinette de Waha, Flavio Ribichini, Gregg W. Stone
I whakaputaina 2012Revisão -
18
A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease mā Albert Schömig, Alban Dibra, Stephan Windecker, Julinda Mehilli, José Suárez de Lezo, Christoph Kaiser, Seung‐Jung Park, Jean-Jacque Goy, Jae‐Hwan Lee, Emilio Di Lorenzo, Jinjin Wu, Peter Jüni, Matthias Pfisterer, Bernhard Meier, Adnan Kastrati
I whakaputaina 2007Revisão -
19
TCT-30 Safety, Clinical Performance and multi-modality imaging data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Corona... mā Michael Haude, Hüseyin İnce, Alexandre Abizaid, Ralph Töelg, Pedro A. Lemos, Clemens von Birgelen, Evald Høj Christiansen, William Wijns, Franz–Josef Neumann, Christoph Kaiser, Éric Eeckhout, Soo Teik Lim, Javier Escaned, Héctor M. García‐García, Ron Waksman
I whakaputaina 2016Artigo -
20
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-bli... mā Juan F. Iglesias, Olivier Müller, Dik Heg, Marco Roffi, David J. Kurz, Igal Moarof, Daniel Weilenmann, Christoph Kaiser, Maxime Tapponnier, Stefan Stortecky, Sylvain Losdat, Éric Eeckhout, Marco Valgimigli, Ayodele Odutayo, Marcel Zwahlen, Peter Jüni, Stephan Windecker, Thomas Pilgrim
I whakaputaina 2019Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Cardiology
Myocardial infarction
Stent
Surgery
Percutaneous coronary intervention
Restenosis
Confidence interval
Drug-eluting stent
Bare metal
Hazard ratio
Pharmacology
Randomized controlled trial
Drug
Revascularization
Sirolimus
Artery
Heart failure
Physics
Biomedical engineering
Cardiomyopathy
Coronary artery disease
Everolimus
Meta-analysis
Perioperative
Radiology
Scaffold
Acute coronary syndrome
Angioplasty